story of the week
Systemic Chemotherapy With or Without Cetuximab in Patients With Resectable Colorectal Liver Metastasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Systemic Chemotherapy With or Without Cetuximab in Patients With Resectable Colorectal Liver Metastasis (New EPOC): Long-Term Results of a Multicentre, Randomised, Controlled, Phase 3 Trial
Lancet Oncol 2020 Jan 31;[EPub Ahead of Print], JA Bridgewater, SA Pugh, T Maishman, Z Eminton, J Mellor, A Whitehead, L Stanton, M Radford, A Corkhill, GO Griffiths, S Falk, JW Valle, D O'Reilly, AK Siriwardena, J Hornbuckle, M Rees, TJ Iveson, T Hickish, OJ Garden, D Cunningham, TS Maughan, JN PrimroseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.